MDBH
MDB Capital Holdings, LLC3.1800
-0.1000-3.05%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Portfolio color, AI efficiencies emerge
Q&A drilled into portfolio underperformers largely glossed over in prepared remarks, with management bullish on Cue Biopharma's partnerships despite execution woes, HeartBeam's game-changing ECG awaiting scale, ClearSign's commercialization push, and Buda's profitable fresh juice pivot. eXoZymes dilution seen as minimal via grants and outsourcing. PatentVest spin-out clarified: 100% owned, partner-funded soon, public by 2027. AI demo wowed—patentability searches cut from 45 to 1.5 hours. Distribution bottlenecks the deal pipeline. Execution risks persist, but tone stayed optimistic.
Key Stats
Market Cap
32.24MP/E (TTM)
2.22Basic EPS (TTM)
1.43Dividend Yield
0%Recent Filings
8-K
Shareholders elect board, ratify auditors
MDB Capital Holdings shareholders overwhelmingly elected seven directors—Christopher Marlett, Anthony DiGiandomenico, George Brandon, Mo Hayat, Susanne Meline, Sean Magennis, and Daniel Torpey—at the December 2, 2025 annual meeting, with over 99% support for each. They ratified RBS&K LLP as auditors for fiscal 2025, drawing 25.5M votes or 84.9% quorum. Board continuity locked in.
10-Q
Q3 FY2025 results
MDB Capital Holdings swung to a Q3 operating loss of $3.8M, 57% narrower y/y, thanks to $1.2M unrealized gains on broker-dealer securities versus prior loss; YTD net loss held steady at $19.5M despite $3.0M equity-method hit from eXoZymes. Compensation plunged 36% y/y to $3.3M on deconsolidation and RSU-to-option swaps, while fee income doubled YTD to $2.1M from February banking deal. Cash dipped to $15.1M, burn slowed to $5.3M YTD operating outflow (versus $8.6M); no debt drawn on $2M revolver (6.75% rate, due 2026). Equity method stake in eXoZymes weighs $38.7M. Tariffs crimp capital raises.
10-Q
Q2 FY2025 results
MDB Capital Holdings posted a Q2 net loss of $8.2M, or $0.83 per Class A share (4,950,632 diluted shares), wider than $4.3M or $0.46 y/y, driven by $2.2M unrealized loss on broker-dealer securities versus $0.9M gain while fee income dried up after Q1's $2.1M (64% y/y growth YTD). Operating costs fell 26% y/y to $5.5M on lower compensation post eXoZymes deconsolidation, yet net operating loss ballooned to $7.4M from equity method losses at 47%-owned eXoZymes. Cash dipped to $17.1M from operations ($3.4M YTD use), with $2M undrawn revolver at 6.75% secured by $2.1M deposit; Public Ventures holds $8.6M net capital, exceeding requirements. Tariffs threaten partner funding.
8-K
Board transitions announced
MDB Capital Holdings announced Matthew Hayden's resignation from the board effective June 30, 2025, to take a new Entrepreneur in Residence role guiding early-stage tech firms. Dan Torpey became Audit Committee Chair on February 13, 2025, leveraging 24 years at Ernst & Young. Smooth transition. These shifts bolster governance while retaining Hayden's expertise amid platform scaling.
10-Q
Q1 FY2025 results
MDB Capital Holdings narrowed its Q1 operating loss to $5.9M from $7.9M y/y, thanks to $2.1M fee income from broker-dealer investment banking that flipped the segment to modest operating profit—yet unrealized losses on securities doubled to $1.5M. Net loss attributable to MDB eased to $6.6M ($0.66/share) from $7.2M ($0.78/share), with EPS matching diluted shares of 4.95M Class A; equity method loss from eXoZymes added $0.9M. Cash burned $1.3M in operations, ending at $19.6M with $20M total liquidity and no debt drawn on $2M revolver. Broker-dealer holds $10.2M net capital, exceeding requirements. New warrants from deals partly offset fair value hits. Tariffs threaten partner funding.
DOMH
Dominari Holdings Inc.
4.51+0.19
FUTU
Futu Holdings Limited
163.39+1.50
LPLA
LPL Financial Holdings Inc.
367.97-5.46
MARA
MARA Holdings, Inc.
10.69-0.01
MC
Moelis & Company
69.37-0.04
MEGL
Magic Empire Global Limited
1.31-0.01
MGHL
Morgan Group Holding Co.
1.95+0.00
NMR
Nomura Holdings Inc
8.18-0.19
OPY
Oppenheimer Holdings, Inc.
73.27+0.84
PLUT
Plutus Financial Group Limited
3.20-0.20